Back to
Cerity Partners LLC
QNCX
2 quarters
Position history for
Cerity Partners LLC's holdings in QUINCE THERAPEUTICS INC
No. Cerity Partners exited its QNCX (Quince Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 189,789 shares worth $635,793. Cerity Partners first reported QNCX in Q4 2025 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$635,793
Total Shares Change
-189,789
Quarter-by-Quarter History